JPH0576924B2 - - Google Patents

Info

Publication number
JPH0576924B2
JPH0576924B2 JP11332486A JP11332486A JPH0576924B2 JP H0576924 B2 JPH0576924 B2 JP H0576924B2 JP 11332486 A JP11332486 A JP 11332486A JP 11332486 A JP11332486 A JP 11332486A JP H0576924 B2 JPH0576924 B2 JP H0576924B2
Authority
JP
Japan
Prior art keywords
substance
compound
chloroform
medium
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP11332486A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62270527A (ja
Inventor
Chosei Seki
Kyoshi Den
Teruyoshi Marunaka
Juji Yamada
Ichiro Yamawaki
Toshio Ootani
Yoshinori Minami
Hitoshi Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP11332486A priority Critical patent/JPS62270527A/ja
Priority to AU72518/87A priority patent/AU599650B2/en
Priority to US07/048,297 priority patent/US4814449A/en
Priority to DE87304268T priority patent/DE3787669T2/de
Priority to EP87304268A priority patent/EP0246091B1/en
Priority to ES87304268T priority patent/ES2059374T3/es
Priority to CA000537277A priority patent/CA1290274C/en
Publication of JPS62270527A publication Critical patent/JPS62270527A/ja
Priority to US07/252,722 priority patent/US4866069A/en
Publication of JPH0576924B2 publication Critical patent/JPH0576924B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP11332486A 1986-05-16 1986-05-16 ４１８１−２物質及びその誘導体を有効成分とする抗腫瘍剤 Granted JPS62270527A (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP11332486A JPS62270527A (ja) 1986-05-16 1986-05-16 ４１８１−２物質及びその誘導体を有効成分とする抗腫瘍剤
AU72518/87A AU599650B2 (en) 1986-05-16 1987-05-05 Substance 4181-2 and its derivatives
US07/048,297 US4814449A (en) 1986-05-16 1987-05-11 Substance 4181-2
DE87304268T DE3787669T2 (de) 1986-05-16 1987-05-14 Substanz 4181-2 und deren Derivate.
EP87304268A EP0246091B1 (en) 1986-05-16 1987-05-14 Substance 4181-2 and its derivatives
ES87304268T ES2059374T3 (es) 1986-05-16 1987-05-14 Substancia 4181-2 y sus derivados.
CA000537277A CA1290274C (en) 1986-05-16 1987-05-15 Substance 4181-2 and its derivatives
US07/252,722 US4866069A (en) 1986-05-16 1988-10-03 Substance 4181-2 and its derivatives having anti-leukemia activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11332486A JPS62270527A (ja) 1986-05-16 1986-05-16 ４１８１−２物質及びその誘導体を有効成分とする抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPS62270527A JPS62270527A (ja) 1987-11-24
JPH0576924B2 true JPH0576924B2 (OSRAM) 1993-10-25

Family

ID=14609347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11332486A Granted JPS62270527A (ja) 1986-05-16 1986-05-16 ４１８１−２物質及びその誘導体を有効成分とする抗腫瘍剤

Country Status (1)

Country Link
JP (1) JPS62270527A (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016020D0 (en) * 2000-06-29 2000-08-23 Inst Biomar Sa New polyciclic xanthones and their use

Also Published As

Publication number Publication date
JPS62270527A (ja) 1987-11-24

Similar Documents

Publication Publication Date Title
US4576961A (en) Antibiotic heterocyclic oxygen compounds and use
JPH0452280B2 (OSRAM)
JPH11100383A (ja) 免疫抑制剤の生産法
NO300812B1 (no) Fremgangsmåte for fremstilling av antitumorsubstans BE-13793C, samt biologisk ren kultur istand til å frembringe denne
KR100659680B1 (ko) 항생 물질 카프라자마이신류 및 그 제조법
US4866069A (en) Substance 4181-2 and its derivatives having anti-leukemia activity
JP3155281B2 (ja) キノロン化合物及びその製法
US5756536A (en) Microbial transformation of taxol and cephalomannine
EP0245012B1 (en) Method for the preparation of 14-hydroxy-6-0-methyl-erythromycin a
WO2000024747A1 (fr) Substance gm-95, procedes de fabrication et d'utilisation correspondants
US4771070A (en) CL-1957A antibiotic compound
EP0173649A2 (en) Novel saframycin A derivatives and process for producing the same
JPH0576924B2 (OSRAM)
US5109122A (en) Antibiotics, dexylosylbenanomicin B
JP3759207B2 (ja) 抗菌剤及び医薬組成物
JP3124373B2 (ja) 免疫抑制物質
CA1321788C (en) Antitumor substance, process for preparing the same and anticancer agent containing the same
EP0332080B1 (en) Bu-3862t antitumor antibiotic
CA2006342A1 (en) Antibiotic a80915 and process for its production
JPH0462317B2 (OSRAM)
JP4730879B2 (ja) キガマイシノン類及びその製造方法、並びに、該キガマイシノン類を含む薬用組成物
KR900005957B1 (ko) 물질 4181-2 및 그의 유도체
EP0333177A2 (en) FR-900493 substance, a process for its production and a pharmaceutical composition containing the same
WO1998022612A1 (fr) Nouveaux composes antitumoraux et utilisation de ces derniers
WO1996002659A1 (fr) Substance it-62-b et composition medicinale la contenant